Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...

Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...

Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...

Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Learn why rare diseases are more common in some communities due to cousin marriages and founder effects in population ...

July saw one of the biggest acquisition deals this year. Several pharma giants shook hands with young biotechs developing small molecules and antibodies born out of various proprietary drug discovery ...

We’re nearly halfway through 2025, and like clockwork, the American Society of Clinical Oncology (ASCO) annual summit took place from the 30th of May to the 3rd of June in Chicago this year. With ...